ASBMB Annual Meeting

Challenged by a pandemic, Harbig pursues a new approach to treating flu

Meet a JBC Herbert Tabor Early Career Investigator Award winner

When Anne Harbig found out she had won an award for her very first authored paper, she was shocked.

Harbig-445x522.jpg
Anne Harbig

"It totally caught me by surprise," Harbig said. The paper was the culmination of all of her data from her Ph.D. research in Eva Böttcher-Friebertshäuser's lab at the Marburg Institute of Virology. "I always wanted to deepen my knowledge about viruses, and I was able to have this great Ph.D. project. I'm very grateful for my supervisor."

Harbig's research takes on the challenge of finding proteases that activate specific strains of influenza, which could be targeted with drugs in order to prevent infection and treat the disease. If inhibiting proteases proves effective in halting influenza infection, these methods could be used to target other enveloped viruses as well, including coronaviruses.

Harbig's project came with all kinds of challenges —wading through piles of transcriptome data, hundreds of in vitro studies with proteases that never activated, and now, the global COVID-19 pandemic that introduced all kinds of disruptions as she continues to pursue the project as a postdoc.

"Sometimes, especially on a Friday when you have the results of the week's experiments and things are not working and everything sucks," she said, "it's good to have the weekend to take a break and have ideas for how to do it differently next week."

To stop flu infection, target host enzymes

Anne Harbig seeks to develop targeted treatments that prevent influenza viruses from entering potential host cells. For a flu infection to begin, the virus must have its surface protein called hemagglutinin cleaved by host enzymes known as proteases.

"A protease is a protein, an enzyme, that cleaves other proteins at specific sites," Harbig explained.

Because the virus cannot enter a cell without a protease present, Harbig and her colleagues are identifying proteases involved in activating certain flu strains so they can develop drugs that can block them.

Harbig used RNA sequencing to search for any segments of mRNA coding for proteases found in the lower respiratory system of mice. Once she identified an array of lung proteases, each one was tested individually for its ability to split apart the hemagglutinin on the surface of influenza B viruses. The proteases that were able to do so were narrowed down further to four candidates that activated influenza B infection in mouse cells.

"The idea is, if we know the protease that activates our virus, we can use protease inhibitors to prevent infection," Harbig said. "If we know all the proteases involved, we can test the inhibitors in murine models, in vivo, and if they work there, then maybe later [we can test them] in human studies."

Harbig has earned her Ph.D. and is continuing to work on the project, hoping to see it reach human clinical trials.

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Guananí Gómez–Van Cortright

Guananí Gómez–Van Cortright is a teacher and freelance science writer.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Listen, learn and support
Pride

Listen, learn and support

June 8, 2023

Four LGBTQIA+ scientists share their stories and reflect on progress and setbacks for inclusivity and support.

2023 PROLAB winners named
Member News

2023 PROLAB winners named

June 2, 2023

Ten early-career scientists will receive grants that will allow them to advance their research by working in the labs of collaborators abroad.

State laws change the landscape for LGBTQIA+ scientists
Pride

State laws change the landscape for LGBTQIA+ scientists

May 31, 2023

New legislation in the past 16 months has banned gender affirming care for transgender teens, teaching children about sexual orientation and gender identity, and drag shows.

Redefining STEM
Pride

Redefining STEM

May 30, 2023

The U.K.-based organization Pride in STEM says it aims to “queer up science spaces” and to “science up queer spaces.”

Awards for Medlock, Bagde and Maquat
Member News

Awards for Medlock, Bagde and Maquat

May 29, 2023

Awards, promotions milestones and more. Find out what's going on in the lives of ASBMB members.

In memoriam: Sorina Popescu
In Memoriam

In memoriam: Sorina Popescu

May 29, 2023

She was a a plant biologist and biochemist whose last studies included several melding science and agriculture on topics ranging from crop stress resistance to plant root microbial community control.